Can virtual doula sessions and home monitoring prevent preeclampsia in black women?
NCT ID NCT07491510
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 5 times
Summary
This study will test a telehealth group prenatal care program called Centering HER in 72 low-income, predominantly Black pregnant women in Kansas who are at moderate or high risk for preeclampsia. Participants will receive routine care plus seven doula-led virtual group sessions, a Bluetooth blood pressure cuff and scale, and optionally an Apple Watch. The goal is to see if this program improves blood pressure monitoring and aspirin use, and ultimately reduces early-onset preeclampsia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral intervention: telehealth group prenatal care (Centering HER) with doula-led sessions, Bluetooth BP cuff/scale, and optional Apple Watch
- What this could lead to
- If successful, this program could offer a practical way to reduce early-onset preeclampsia in high-risk, low-income Black women through better monitoring and aspirin adherence.
- What could go wrong
- This is a small, early feasibility study (72 participants) that has not yet started recruiting. It tests a behavioral program, not a drug, so the impact may be limited and may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * English or Spanish speaking * \<13 weeks gestations * \>18 years old * moderate or high risk for hypertensive disorders in pregnancy Exclusion Criteria: * less than18 years of age * not receiving prenatal care * not eligible for doula care * no risk factors for hypertensive disorders in pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aspirin prophylaxis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.